Format

Send to

Choose Destination
Blood. 2018 Jul 26;132(4):448-452. doi: 10.1182/blood-2017-03-773028. Epub 2018 Jun 12.

Normalizing hepcidin predicts TMPRSS6 mutation status in patients with chronic iron deficiency.

Author information

1
Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.
2
Dana-Farber Cancer Institute, Boston, MA.
3
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.
4
Department of Molecular Medicine and Medical Biotechnologies, Federico II University Medical School, Naples, Italy.
5
CEINGE Biotecnologie Avanzate, Naples, Italy.
6
Department of Pathology, Boston Children's Hospital, Boston, MA.
7
Intrinsic LifeSciences, La Jolla, CA.
8
Division of Newborn Medicine, and.
9
Division of Genetics and Genomics, Department of Medicine, Boston Children's Hospital, Boston, MA.
10
Division of Pediatric Hematology-Oncology, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada; and.
11
Department of Pathology, Yale University, New Haven, CT.
PMID:
29895660
PMCID:
PMC6071554
[Available on 2019-07-26]
DOI:
10.1182/blood-2017-03-773028
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center